Assets
+ Astellas Pharma
History
2023: Astellas Pharma bought Iveric Bio
On May 1, 2023, the Japanese pharmaceutical holding Astellas announced the conclusion of an agreement on the acquisition of the American company Iveric Bio. This deal is expected to enable Astellas to strengthen its position in the ophthalmic therapy market. Read more here.
| The site content is translated by machine translation software powered by PROMT. The machine-translated articles are not always perfect and may contain errors in vocabulary, syntax or grammar. Read original article If you find inaccuracies or errors in the results of machine translation, please write to editor@tadviser.ru. We will make every effort to correct them as soon as possible. |